How Genzyme Became Vulnerable To Sale
BOSTON (CBS) - Analysts say Genzyme's decision to manufacture a third drug at it's Allston facility eventually led to its sale - even though the drug saved lives.
Lisa van der Pool of the Boston Business Journal reports.
